This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.94% per year. These returns cover a period from January 1, 1988 through June 1, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View the Zacks #1 Rank List
reit: Archive
Medical Properties Q2 NFFO Misses Estimates, Revenues Rise Y/Y
by Zacks Equity Research
MPW's Q3 results show higher revenues but lower NFFO per share as interest expenses weigh on performance.
earnings finance reit
Is Realty Income Stock a Buy, Hold, or Sell Before Q3 Earnings?
by Moumita C. Chattopadhyay
Realty Income's Q3 results are set to show steady growth, backed by resilient occupancy, diversification and disciplined expansion.
finance reit retail
Federal Realty Beats Q3 FFO & Revenue Estimates, Raises 2025 View
by Zacks Equity Research
FRT tops Q3 FFO and revenue estimates, driven by strong leasing gains and occupancy growth, and lifts its 2025 outlook.
earnings finance reit
Do Options Traders Know Something About Farmland Partners Stock We Don't?
by Zacks Equity Research
Investors need to pay close attention to FPI stock based on the movements in the options market lately.
reit
Cousins Properties Q3 FFO Matches Estimates, Revenues Top, '25 View Up
by Zacks Equity Research
CUZ posts steady Q3 results with strong leasing and higher revenues while boosting its 2025 FFO outlook.
finance reit
Vornado Realty to Report Q3 Earnings: What's in Store for the Stock?
by Zacks Equity Research
VNO's Q3 results are set to show modest revenue and FFO gains, fueled by solid leasing in premium office assets.
finance reit
Zillow Group's Q3 EPS Lags Estimates, Revenues Grow Y/Y
by Zacks Equity Research
Z's Q3 revenues jump 16.4% on surging rentals and mortgage growth, even as higher costs weigh on earnings.
finance reit
VICI Properties' Q3 AFFO & Revenues Beat Estimates, Improve Y/Y
by Zacks Equity Research
VICI posts higher Q3 AFFO and revenues and boosts its 2025 outlook amid solid income growth across business lines.
finance reit
New Strong Buy Stocks for Oct. 31: PMT, NWG, and More
by Zacks Equity Research
PMT, NWG, PAHC, CNC and ACNB have been added to the Zacks Rank #1 (Strong Buy) List on October 31, 2025.
finance medical reit
The Zacks Analyst Blog Highlights Simon Property, Realty Income and The Macerich
by Zacks Equity Research
Simon Property, Realty Income, and Macerich could deliver upside this earnings season as retail REIT fundamentals stabilize.
reit